JPRN-jRCT2080220981未知3 期
Phase 3 Study of KW-6500 (Safety Study for Extended Long-Term Self-Injection at Home in Patients with Parkinson's Disease)
Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2010年1月27日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who have given written informed consent
- •- Patients who have completed the 6500-004 study
排除标准
- 未提供
研究者
相似试验
未知
3 期
ong-Term Safety Study of KW-6500Parkinson's DiseaseJPRN-jRCT2080220819Kyowa Hakko Kirin Co., Ltd.
已完成
3 期
Long-Term Safety Study of KW-6500 in Patients With Parkinson's DiseaseParkinson's DiseaseNCT00955318Kyowa Kirin Co., Ltd.58
未知
3 期
Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 (6500-004)Parkinson's DiseaseJPRN-jRCT2080220980Kyowa Hakko Kirin Co., Ltd.20
进行中（未招募）
1 期
Research study to determine whether an investigational drug, SHP647, is safe and effective long term in the treatment of moderate to severe Ulcerative Colitis or Crohn's Disease (AIDA)EUCTR2017-000574-11-HUShire Human Genetic Therapies, Inc.2,453
进行中（未招募）
1 期
Research study to determine whether an investigational drug, SHP647, is safe and effective long term in the treatment of moderate to severe Ulcerative Colitis (AIDA)EUCTR2017-000574-11-ESShire Human Genetic Therapies, Inc.1,114